Oral compositions comprising lp(a) inhibitor compounds

TW202641497APending Publication Date: 2026-10-16ELI LILLY & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144388
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-14
Filing Date
2025-11-14
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080604_001
    Figure TWG2TA001080604_001
  • Figure TWG2TA001080604_002
    Figure TWG2TA001080604_002
  • Figure TWG2TA001080604_003
    Figure TWG2TA001080604_003
Patent Text Reader

Abstract

Oral compositions including a Lp(a) inhibitor compound and histidine. Oral compositions including muvalaplin and histidine. New polymorphs of muvalaplin, such as muvalaplin hydrate Form A, muvalplin hydrate Form B, muvalaplin hemihydrate, and muvalaplin hydrate
Need to check novelty before this filing date? Find Prior Art